ArticleFrontiers in cardiovascular medicine2026
Upfront triple combination therapy with selexipag: insights from a real world cohort in Chinese patients with pulmonary arterial hypertension.
Xiaopei Cui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.